In memory and mouring of our Chief Scientific Officer
Prof. Dr. rer. nat. Dr. med. habil. Manfred Schmitt
Manfred Schmitt was a biochemist and cell biologist by training (Johannes Gutenberg University, Mainz, Germany) and a tenured professor emeritus at the Medical School of the Technical University of Munich, Germany. As a full professor of Experimental Gynecology, from 1987 to 2015, he has headed the Clinical Research Unit of the Department of Obstetrics and Gynecology at the university hospital Klinikum rechts der Isar. During that time, he supervised translational research in the area of gynecological oncology and gestational diseases as a focus of the department. Manfred Schmitt was a member of the Translational Research Advisory Committee of the EORTC, Brussels, and has been the chairman of the PathoBiology Group of the EORTC for six years.
He was cooperating within a trans-European and trans-world network regarding cancer biomarkers as tools for patient diagnosis, prognosis, disease monitoring, and therapy response, also with foreign bodies such as AACR, ASCO, NCI, FDA, and the WIN consortium. Since 1989, Manfred Schmitt was the coordinator or partner in publically funded national (e.g. DFG, BMBF, Wilhelm-Sander Foundation, German Cancer Aid) and EU-funded projects (ESPRIT-3, TMR, Marie Curie, 4th Medical and Health, Biomed-1, Biomed-2, FP6/FP7) with focus on therapy response/resistance markers in cancer.
He was board member of the Henner-Graeff Foundation, of the Frey-Werle Foundation, and the breast cancer foundation PATH. He was member of the Scientific Advisory Board of WIN (Worldwide Innovative Networking Consortium in personalized cancer medicine). He was listed as a co-inventor on 75 patents and has published >420 articles in international scientific journals or books.